Elevated circulating SAA levels are consistently observed in conditions with a low-grade inflammatory component, such as in atherosclerosis, diabetes and obesity and are associated with increased risk of clinical coronary events (10, 11). The gene discussed is SAA1; the disease is atherosclerosis.